Benzinga | Nov 5, 2021 09:32AM EDT

Kura Oncology Q3 EPS $(0.50) Beats $(0.54) Estimate

Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.54) by 7.41 percent. This is a 19.05 percent decrease over losses of $(0.42) per share from the same period last year.